FDA PDUFA review goal date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT)Assuming ...
Company Achieves Key Clinical Milestone with more than 20 Patients Enrolled in Weekly Dosing Cohort of Phase 1 Trial of Decoy20Pharmacodynamic ...
Bharatiya Janata Party leaders said the move replacing the symbol with a Tamil letter for ‘ru’ showed the Dravida Munnetra ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback